Scoop has an Ethical Paywall
Geneious present at Antibody Engineering conference
Jannick Bendtsen, PhD, will address how next generation sequencing (NGS) is accelerating the field of therapeutic antibody research at the Antibody Engineering & Therapeutics conference, at the Manchester Grand Hyatt in San Diego, on December 11.
Dr Bendtsen’s talk - titled NGS is Accelerating Therapeutic Antibody Discovery: What Lies Beyond? - will examine how scientists face a growing need for software that enables efficient and accurate analysis of rapidly expanding data sets. He will also outline how Biomatters’ Geneious Biologics cloud-based enterprise software for analysis of antibodies and related constructs meets that need.
Dr Bendtsen is Vice President of Technology Services at Biomatters and development leader of Geneious Biologics. He will be joined in his presentation by Dr Liuhong Chen, Ph.D., Discovery Biology Team Lead at Bicycle Therapeutics.
Scientific Briefing: NGS is Accelerating
Therapeutic Antibody Discovery: What Lies
Beyond?
Presenter: Jannick Bendtsen, PhD, Vice President of
Technology Services, Biomatters
Event: Antibody
Engineering & Therapeutics
Location: Manchester Grand
Hyatt, San Diego
Date: 11 December 2018
Time: 12:00
PM (PT), Bayview Room
Hugh Grant: How New Tech Helps Kids Love Soccer More
Bill Bennett: Download Weekly - 100% claim lands One New Zealand in criminal court action
FSCL: Woman Scammed Out Of $25,000 After Job Offer On LinkedIn
NIWA: Cheers To Crustaceans - New Species Named After Welly Brewery
MBIE: Trans-Tasman Earth Observation Research Studies Confirmed
NZ Association of Scientists: Royal Society Te Apārangi Governance Submissions Close - NZAS Submission
